Home > Products > 59803-98-4

59803-98-4
UK 14,304

Catalog#:1P003P0I

CAS:59803-98-4

MDL:MFCD00153878

Molecular Formula:C11H10BrN5

Molecular Weight:292.1346

UN Number:

Haz Class:

Packing Group:

Synonyms: 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate; 5-bromo-6-(imidazolidinylideneamino)quinoxaline; brimonidine tartrate; KS-00000F2V; KS-000048KL; ZX-AS004769; Tox21_110299; Tox21_501216; AC-162; ANW-59812; NSC318825; PDSP1_000640; PDSP2_000635; brimonidine tartrate (1:1); SBB080815; ZINC21303210; AKOS005267239; IMED608142799; Tox21_110299_1; AN-6804; CCG-205290; CS-2892; DB00484; GS-3236; brimonidine tartrate (1:1), (S-(R*,R*))-isomer; LP01216; MCULE-4542695850; NC00638; NSC-318825; TRA0032007; MRF-0000657; NCGC00016069-01; NCGC00016069-02; NCGC00016069-03; NCGC00016069-04; brimonidine tartrate, (R-(R*,R*))-isomer; NCGC00016069-05; NCGC00016069-06; NCGC00016069-07; NCGC00016069-08; NCGC00016069-10; NCGC00016069-11; NCGC00016069-12; NCGC00016069-13; NCGC00023468-02; NCGC00023468-04; bromoxidine; NCGC00023468-05; NCGC00023468-06; NCGC00023468-07; NCGC00261901-01; AJ-78420; BC215787; CC-25204; CJ-16916; CPD000058355; SAM002548958; mirvaso; UK14,304; LS-142950; ST2406733; TC-148557; B4132; EU-0101216; FT-0082636; FT-0630717; FT-0650586; UK 14304-18; Ratio Brimonidine; C07886; D07540; 5-bromo-6-(2-imidazolidinylidenamino)quinoxaline; 5-bromo-6-(2-imidazolin-2-ylamino) quinoxaline; 5-Bromo-6-(2-imidazolin-2-ylamino)-quinoxaline; 6-Quinoxalinamine,5-dihydro-1H-imidazol-2-yl)-; (5-bromoquinoxalin-6-yl)-2-imidazolin-2-ylamine; 803B984; A832477; C-18323; ratio-Brimonidine; L000615; SR-01000000023-2; SR-01000000023-4; BRD-K68264559-001-10-0; Z802671510; 6-Quinoxalinamine,5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-; (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine; 5-bromanyl-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine; 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- (9CI); mirvaso; Sanrosa; Alphagan; Alphagan P; Sanrosa; Lumify; BRIMONIDINE TARTRATE; ratio-Brimonidine; Ratio Brimonidine; brimonidine Purite; D03ACG; D0AE3X; UK 14,304; D0GD9D; brimonidine tartrate (1:1); 5-bromo-6-(imidazolin-2-ylamino)quinoxaline; C11-H10-Br-N5; CID2435; AGN190342; AR-1G7332; Allergan brand of brimonidine tartrate; Ratiopharm brand of brimonidine tartrate; UK14,308; 5-bromo-6-(imidazolin-2-ylamino)quinoxaline; UK 14,304 18; Brimonidine (bioerodible, extended release); brimonidine tartrate, (R-(R*,R*))-isomer; Pharm-Allergan brand of brimonidine tartrate; UK 14,308; 2436B; U-104; UK14,30418; UK 14,30418; UK 14,304 18; C015620; UK 14,304-18; brimonidine tartrate (1:1), (S-(R*,R*))-isomer; D000068438; 5-bromo-6-(2-imidazolin-2-ylamino)quinoxaline d-tartrate; Brimonidine base/5-Bromo-6-(imidazolin-2-ylamino)quinoxaline; 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1); 70359-46-5; 7268-58-8; 79570-19-7; UK 14,30418; UK 14,308; UK 14304; UK 14308; UK-14,304-18; UK-14,308; UK-14304; UK14,30418; AGN 190342; UK14,308; UK14304; brimonidine; 59803-98-4; Bromoxidine; UK 14,304; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine; 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine; UK-14304; 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline; AGN-190342; AGN 190342; UNII-E6GNX3HHTE; Brimonidine [INN:BAN]; UK 14304; C11H10BrN5; MLS000069370; 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-; E6GNX3HHTE; CHEMBL844; AGN-190342; AGN190342; BRN 0751629; SMR000058355; CHEBI:3175; LK 14304-18; Brimonidine, 98%; MFCD00153878; NCGC00016069-09; AK-35795; EN300-50880; DSSTox_CID_25221; Alphagan; DSSTox_RID_80758; DSSTox_GSID_45221; 5-Bromo-N-(2-imidazolin-2-yl)-6-quinoxalinamine; [3H]brimonidine; CAS-59803-98-4; SR-01000000023; brimonidina; brimonidinum; Brimonidine (INN); UK14304; Alphagan P; Tocris-0425; [3H]-UK14304; UK 14308; Opera_ID_612; Lopac-U-104; UK-14,308; 5-bromo-6-(imidazolidinylideneamino)quinoxaline; UK 14,304-18; UK-14,304-18; AC1L1DO5; brimonidine; AC1Q24IC; AC1Q26LW; cid_2435; Lopac0_001216; SCHEMBL24670; GTPL520; MLS001076349; ARONIS24406; BIDD:GT0649; GTPL5386; brimonidine Purite; DTXSID3045221; BDBM34572; CTK5B0525; XYLJNLCSTIOKRM-UHFFFAOYSA-N; 5-brom-n-(4,5-dihydro-1h-imidazol-2-yl)chinoxalin-6-amin; HMS3259P09; HMS3263D14; HMS3266O03; HMS3675K05; HY-B0659;

Keywords: 59803-98-4,MFCD00153878,1P003P0I,UK 14,304,C11H10BrN5

Inquire
Catalog# Purity Size Price Dis. Price Availability Quantity
1P003P0I 98% 1mg $6.00 $4.00 In Stock USA ADD TO CART BUY NOW
1P003P0I 98% 5mg $7.00 $5.00 In Stock USA ADD TO CART BUY NOW
1P003P0I 98% 10mg $10.00 $8.00 In Stock USA ADD TO CART BUY NOW
1P003P0I 98% 50mg $25.00 $19.00 In Stock USA ADD TO CART BUY NOW
1P003P0I 98% 100mg $47.00 $36.00 In Stock USA ADD TO CART BUY NOW
1P003P0I 98% 250mg $57.00 $43.00 In Stock USA ADD TO CART BUY NOW
1P003P0I 98% 1g $110.00 $83.00 In Stock USA ADD TO CART BUY NOW
1P003P0I 98% 5g $329.00 $247.00 In Stock USA ADD TO CART BUY NOW

Copyright C 2019 1PlusChem LLC. All Right Reserved